28 reports

Key Features of the Report: - Addiction Disorder Patient Flow - Addiction Disorder Prevalence - Addiction Disorder Diagnosed Patients - Addiction Disorder Treated Patients

  • Addictions
  • Mental Health
  • Europe
  • World
  • Forecast

Key Features of the Report: - Addiction Disorders: Disease Definition - Addiction Disorders Patient Flow - Addiction Disorders Prevalence - Addiction Disorders Diagnosed Patients - Addiction Disorders Treated Patients

  • Addictions
  • Mental Health
  • Europe
  • World
  • Forecast

Key Features of the Report: - Addiction Disorder Patient Flow - Addiction Disorder Prevalence - Addiction Disorder Diagnosed Patients - Addiction Disorder Treated Patients

  • Addictions
  • Europe
  • France
  • Germany
  • Forecast

Drug Addiction Rehabilitation Hospitals a) Market Characteristics b) Market Trends & Strategies ##. ##.

  • Addictions
  • Hospital
  • Psychoactive Drug Consumption
  • World
  • Market Size
  • SEASIDE HEALTHCARE ACQUIRED ACCESS MENTAL HEALTH AGENCY (MHA) OF GEORGIA
  • Global Residential Substance Abuse and Mental Health Facilities Market, 2017, Split By Segments, $ Billion

Medications and Therapies for Alcohol Use Disorders - Many substance abuse and drug addiction facilities use medicines along with therapies to aid in alcohol de-addiction.

  • Addictions
  • Healthcare
  • Hospital
  • Mental Health
  • Psychoactive Drug Consumption
  • CENTRE FOR ADDICTION AND MENTAL HEALTH - FINANCIAL PERFORMANCE*
  • Major players
  • Addictions
  • Mental Health
  • Psychoactive Drug Consumption
  • Canada
  • Forecast
  • ECONOMIC IMPACT OF SUBSTANCE ABUSE

Smoking addiction and opium addiction have fewer marketed products.

  • Addictions
  • World
  • Actavis plc
  • Allergan plc
  • Pfizer Inc.
  • Products and services segmentation (2017)
  • SIMILAR INDUSTRIES
  • Addictions
  • Mental Health
  • Psychoactive Drug Consumption
  • Canada
  • Forecast
  • About this Industry
  • Healthcare reform will provide mental health and substance abuse coverage, aiding demand

American Addiction Centers Estimated market share: ##. ##% American Addiction Centers (AAC) is a leading provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction.

  • Addictions
  • Mental Health
  • Psychoactive Drug Consumption
  • United States
  • Forecast
  • Alcohol Addiction - Dormant Projects
  • Alcohol Addiction - Product Development Milestones
  • Addictions
  • Pharmaceutical
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • Products and services segmentation (2017)
  • Tools of the Trade: Growth Strategies for Success

Outpatient substance abuse clinics often use methadone to treat heroin addiction.

  • Addictions
  • Mental Health
  • Psychoactive Drug Consumption
  • United States
  • Forecast
  • PRODUCTS & SERVICES CONTINUED
  • MAIN ACTIVITIES
  • Addictions
  • Clinic
  • Psychoactive Drug Consumption
  • United States
  • Forecast
  • Alcohol Addiction - Dormant Projects
  • Alcohol Addiction - Product Development Milestones
  • Addictions
  • Pharmaceutical
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • INDUSTRY DEFINITION
  • SIMILAR INDUSTRIES
  • Addictions
  • Healthcare
  • United States
  • Forecast
  • PLAYER PERFORMANCE
  • MAJOR MARKETS CONTINUED

It is used to treat depression, anxiety, eating disorders and addiction.

  • Addictions
  • Mental Health
  • Pathology
  • United Kingdom
  • Forecast
  • DRUG ADDICTION - DORMANT PROJECTS
  • ALCOHOL ADDICTION - PIPELINE BY XENOPORT INC
  • Addictions
  • United States
  • Company
  • Product Initiative
  • Omeros Corporation
  • Clinical Trial profile. 318 Trial Title
  • Clinical Trial profile. 964 Trial Title
  • Addictions
  • Clinical Trial
  • Pharmaceutical
  • United States
  • World
  • Latest Clinical Trials News on Alcohol Addiction
  • Clinical Trial profile. 29 Trial Title
  • Addictions
  • Neurology
  • United States
  • World
  • Alkermes plc
  • Target
  • Target
  • Addictions
  • Neurology
  • United States
  • World
  • Alkermes plc

The federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, which was enacted in October 2008, requires that employersponsored group health plans of ## or more employees, which provide cover for mental health or addiction treatment, must provide cove

  • Addictions
  • Hospital
  • Specialty Hospital
  • United States
  • Forecast
  • applications directed to the link between PDE7 and addiction and compulsive disorders.
  • Nicotine Addiction - Pipeline by CV Sciences Inc, H1 2018
  • Addictions
  • Smoking Cessation
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd
  • Drug Addiction - Drug Profiles
  • Drug Addiction - Dormant Projects
  • Addictions
  • Opioid
  • Therapy
  • United States
  • Product Initiative
  • Drug Addiction - Drug Profiles
  • VACCINE FOR COCAINE ADDICTION - DRUG PROFILE
  • Addictions
  • Opioid
  • Therapy
  • United States
  • Product Initiative
  • Addiction - Recent Pipeline Updates
  • ADDICTION - PIPELINE BY LOHOCLA RESEARCH CORPORATION, H2 2015
  • Addictions
  • Research And Development
  • United States
  • Company
  • Product Initiative
  • Sep 12, 2016: Alkermes Launches Competitive Grants Program to Support People Affected by Mental Health and Substance Use Disorders
  • Sep 12, 2016: Alkermes Launches Competitive Grants Program to Support People Affected by Mental Health and Substance Use Disorders

" Alkermes is grounded in our deep commitment to the treatment of addiction and serious mental illness.

  • Addictions
  • Psychotic Disorder
  • United States
  • Company Financials
  • Alkermes plc

He has extensive addiction experience and a passion for integrated treatment approaches.

  • Addictions
  • Healthcare
  • United States
  • Company Financials
  • Catasys, Inc.
  • Clinical Trial Profile Snapshots

Addiction, Pathological Gambling Completed Phase II Interventional acetylcysteine Yale University National Institute on Drug Abuse ## Sep 2009 ## Sep 2012 ## ## ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Sta

  • Addictions
  • Mental Health
  • Neurology
  • World
  • Product Initiative
  • SK Biopharmaceuticals Co., Ltd. - Dormant Developmental Projects,2016
  • Addictions
  • Biopharmaceutical
  • Dementia
  • Therapy
  • SK Biopharmaceuticals Co., Ltd.